For millions of low-income Americans on Medicaid who struggle with obesity, diabetes, or heart disease, a major barrier may be falling in 2026: GLP-1 medications like Ozempic and Wegovy \u2014 which can cost over $1,000 per month without insurance \u2014 are coming to Medicaid coverage through a new federal program launching as early as May 2026.<\/p>\n
What Happened
\nThe Centers for Medicare and Medicaid Services (CMS) announced the BALANCE Model \u2014 Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth \u2014 a new voluntary program enabling state Medicaid agencies to cover GLP-1 medications used for weight management and metabolic health improvement. The program launches in Medicaid as early as May 2026.<\/p>\n
What Are GLP-1 Medications?
\nGLP-1 receptor agonists were originally developed to treat type 2 diabetes but have shown significant effectiveness for weight loss and cardiovascular risk reduction. Well-known options include:<\/p>\n
Ozempic \/ Wegovy (semaglutide) \u2014 Novo Nordisk
\nZepbound \/ Mounjaro (tirzepatide) \u2014 Eli Lilly
\nVictoza \/ Saxenda (liraglutide) \u2014 Novo Nordisk
\nClinical studies show these medications can produce 15\u201320% weight loss over 12\u201316 months, along with improvements in blood sugar and cardiovascular outcomes.<\/p>\n
What This Means for Medicaid Recipients
\nLow or no cost access: Medicaid enrollees in participating states may access GLP-1 medications with standard cost-sharing (often $0 or very low copays)
\nLifestyle support included: The model pairs medication with nutrition counseling and behavioral health resources
\nVoluntary for states: Each state decides whether to participate \u2014 check your state’s Medicaid agency
\nWho May Qualify
\nBody mass index (BMI) of 30 or higher, or BMI of 27 or higher with a weight-related condition
\nType 2 diabetes, cardiovascular disease, or other qualifying metabolic conditions
\nEnrolled in a participating state Medicaid plan
\nHow to Access GLP-1 Coverage Starting May 2026
\nCheck if your state is participating \u2014 contact your state Medicaid agency or visit medicaid.gov
\nTalk to your doctor \u2014 confirm you have a qualifying condition
\nRequest a prior authorization \u2014 your doctor submits documentation to your Medicaid plan
\nEnroll in lifestyle support programming \u2014 required under the BALANCE Model
\n\ud83c\udfe5 Not on Medicaid Yet? Check If You Qualify
\nA family of four earning under approximately $40,000\/year may qualify for Medicaid in most states. eHealth can help you check eligibility and find the right plan \u2014 free of charge.<\/p>\n
Check Medicaid Eligibility \u2192
\nFrequently Asked Questions
\nMy state doesn’t participate. Can I still get GLP-1 medications?
\nYou may still get them for diabetes treatment under existing Medicaid coverage. Check with your state Medicaid agency for weight management coverage.<\/p>\n
Are there side effects?
\nGLP-1 medications can cause nausea, vomiting, and diarrhea especially when starting. Discuss all risks with your doctor before starting.<\/p>\n
When will Medicare cover GLP-1 for weight loss?
\nThe BALANCE Model includes a Medicare Part D component launching January 2027.<\/p>\n
Source: Centers for Medicare and Medicaid Services \u2014 cms.gov. Updated March 16, 2026.<\/p>\n","protected":false},"excerpt":{"rendered":"
For millions of low-income Americans on Medicaid who struggle with obesity, diabetes, or heart disease, a major barrier may be falling in 2026: GLP-1 medications like Ozempic and Wegovy \u2014 which can cost over $1,000 per month without insurance \u2014 are coming to Medicaid coverage through a new federal program launching as early as May […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-25","post","type-post","status-publish","format-standard","hentry","category-family"],"yoast_head":"\n